Tag Archives: Sorrento Therapeutics

Analysts Offer Insights on Healthcare Companies: Sorrento Therapeutics (NASDAQ: SRNE) and Aptevo Therapeutics Inc (NASDAQ: APVO)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Sorrento Therapeutics (NASDAQ:SRNE) and Aptevo Therapeutics Inc (NASDAQ:APVO) with bullish sentiments. Sorrento Therapeutics (SRNE) H.C. Wainwright analyst Ram Selvaraju reiterated a Buy

Sorrento Therapeutics (SRNE) Gets a Buy Rating from Oppenheimer

In a report released today, Mark Breidenbach from Oppenheimer maintained a Buy rating on Sorrento Therapeutics (NASDAQ: SRNE), with a price target of $10. The company’s shares closed yesterday at $5.45. Breidenbach observed: “Thursday, Sorrento reported 2Q results and we

H.C. Wainwright Keeps a Buy Rating on Sorrento Therapeutics

In a report issued on June 11, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Sorrento Therapeutics (NASDAQ: SRNE), with a price target of $40. The company’s shares opened today at $7.30. Selvaraju noted: “We draw investors’ attention

H.C. Wainwright Reaffirms Their Buy Rating on Sorrento Therapeutics

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Sorrento Therapeutics (NASDAQ: SRNE), with a price target of $40. The company’s shares closed on Friday at $7.45. Selvaraju commented: “We draw investors’ attention to

Sorrento Therapeutics Gets a Buy Rating from H.C. Wainwright

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Sorrento Therapeutics (NASDAQ: SRNE) today and set a price target of $40. The company’s shares closed on Friday at $7.60. Selvaraju wrote: “We reiterate our Buy rating and 12-month target

Oppenheimer Keeps a Buy Rating on Sorrento Therapeutics

Oppenheimer analyst Mark Breidenbach maintained a Buy rating on Sorrento Therapeutics (NASDAQ: SRNE) today and set a price target of $10. The company’s shares closed yesterday at $7.35. Breidenbach wrote: “Thursday, Sorrento reported 1Q results and we recently went on